Date:
February 6, 2020
Time:
12:00pm - 1:00pm
Place:
N-225
* Note: Special Time and Location - 4:00 pm - Genentech Auditorium*
** BMS RECRUITMENT WEEKEND **
Alex Marson (faculty)
"Designing better immunotherapy with CRISPR"
Wei et al. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy. Nature volume 576, pages471–476(2019).
Julie Garcia (student)
"Oops…we cured cancer??? Genome Wide CRISPR Cas-9 Screening Reveals Ubiquitous T Cell Cancer Targeting via the monomorphic MHC-class I related MR1 protein"
Crowther MD, Dolton G, Legut M, et al. Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1. Nat Immunol. January 2020. doi:10.1038/s41590-019-0578-8
Coaches: Kole Roybal and Justin Eyquem